Innovative Nanoparticles Illuminate and Eliminate Brain Tumors

Researchers from the University of Technology Sydney, Harvard, and Henan universities have developed a novel 'dual-action' nanoparticle capable of illuminating concealed glioblastoma cells during surgical procedures and eliminating residual cancer afterward. This ultra-thin substance emits a glow under near-infrared light, enabling surgeons to identify tumor clusters as small as 44 micrometers, surpassing the detection limits of current imaging technologies. A specific targeting molecule facilitates its passage across the blood-brain barrier. After the visible tumor is excised, the same material is reactivated by light to transform the tumor's own biochemical environment into oxygen and heat that kill cancer cells. In studies involving mice, every treated specimen lived for a minimum of 60 days post-surgery, in contrast to just 42 days for those undergoing surgery alone, without any indications of neurological impairment. Researchers emphasize that this method remains several years away from human clinical trials.
Disclosure:
This video contains stock footage and content created or enhanced using AI-assisted tools.

ai-generated